Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Nat Genet. 2022 Dec 20;55(1):89–99. doi: 10.1038/s41588-022-01222-9

Table 1.

Previously unreported colorectal cancer risk associations identified by genome-wide association study analysis.

SNP Cytoband Position (bp, GRCh37) Risk/Alt Allele RAF (EUR) RAF (EAS) OR
(95% CI)
P-value I2 (%) Closest gene (RefSeq)
rs34963268 * 1p36.12 22,710,877 G/C 0.84 0.77 1.07 (1.05–1.09) 6.28E-16 31 ZBTB40
rs5028523 1q24.3 172,864,224 A/G 0.53 0.05 1.04 (1.03–1.06) 1.44E-08 0 TNFSF18
rs12137232 1q32.1 201,885,446 G/T 0.52 0.19 1.04 (1.03–1.05) 7.71E-09 15 LMOD1
rs12078075 1q32.1 205,163,798 G/A 0.09 0 1.07 (1.05–1.10) 1.94E-08 0 DSTYK
rs2078095 1q43 240,408,346 G/A 0.28 0.23 1.04 (1.03–1.06) 2.08E-08 0 FMN2
rs4668039 2q24.3 169,025,379 G/A 0.2 0.52 1.04 (1.03–1.06) 3.32E-08 12 STK39
rs704417 3p14.1 64,252,424 T/C 0.51 0.89 1.05 (1.03–1.06) 4.35E-10 0 PRICKLE2
rs7623129 * 3p14.1 64,624,426 C/T 0.56 0.51 1.04 (1.02–1.05) 1.51E-08 5 ADAMTS9
rs2388976 4q26 115,502,406 A/G 0.44 0.45 1.04 (1.02–1.05) 1.75E-08 17 UGT8
rs10006803 4q31.3 151,501,208 C/G 0.5 0.45 1.04 (1.02–1.05) 2.58E-08 0 LRBA
rs1426947 4q34.1 175,420,523 T/C 0.42 0.66 1.04 (1.03–1.05) 7.48E-10 0 HPGD
rs3930345 5q14.3 82,881,255 C/T 0.8 0.75 1.05 (1.03–1.06) 6.82E-09 10 VCAN
rs472959 5q35.1 172,324,558 A/G 0.46 0.46 1.04 (1.03–1.05) 4.71E-09 24 ERGIC1
rs1294437 6p25.1 6,749,789 C/T 0.65 0.23 1.04 (1.03–1.06) 1.21E-08 0 LY86
rs9379084 * 6p24.3 7,231,843 G/A 0.88 0.8 1.07 (1.05–1.09) 1.79E-12 9 RREB1
rs209142 * 6p22.1 28,862,617 C/G 0.39 0.52 1.04 (1.02–1.05) 3.66E-08 20 TRIM27
rs57939401 6p21.1 45,572,071 A/G 0.1 0.13 1.07 (1.04–1.09) 3.51E-10 0 RUNX2
rs6912214 * 6p12.1 55,721,302 T/C 0.55 0.83 1.04 (1.03–1.05) 1.55E-08 20 BMP5
rs145997965 * 6q21 106,482,613 C/T 0.02 0 1.21 (1.13–1.29) 1.26E-08 0 PRDM1
rs6911915 6q22.1 117,809,031 C/T 0.44 0.43 1.05 (1.03–1.06) 3.99E-12 3 DCBLD1
rs151127921 6q23.2 133,993,925 T/C 0.02 0 1.17 (1.11–1.24) 3.19E-08 24 EYA4
rs1182197 7p22.2 2,863,289 A/C 0.63 0.7 1.04 (1.03–1.05) 5.32E-09 0 GNA12
rs12539962 7q11.23 73,167,259 C/T 0.72 0.63 1.04 (1.03–1.05) 2.96E-08 27 ABHD11
rs2527927 7q22.1 99,477,426 G/A 0.55 0.71 1.04 (1.03–1.06) 3.31E-10 2 OR2AE1
rs60911071 8p21.2 23,664,632 G/C 0.95 0.64 1.06 (1.04–1.09) 2.24E-08 0 STC1
rs826732 8q12.1 59,742,639 C/G 0.5 0.59 1.04 (1.03–1.06) 6.26E-10 7 TOX
rs11557154 9p13.3 34,107,505 T/C 0.14 0.59 1.05 (1.04–1.07) 6.02E-10 14 DCAF12
rs10978941 9q31.2 110,373,819 C/T 0.83 0.87 1.06 (1.04–1.08) 2.29E-12 0 KLF4
rs7038489 * 9q34.2 136,682,468 C/T 0.89 0.99 1.08 (1.05–1.1) 1.1E-08 48 VAV2
rs11789898 9q34.2 136,925,663 T/G 0.18 0.08 1.05 (1.04–1.07) 6.28E-09 36 BRD3
rs1775910 * 10p12.1 29,096,942 G/C 0.25 0.32 1.04 (1.03–1.06) 3.11E-08 17 LOC100507605
rs1773860 10p12.1 29,291,556 T/C 0.49 0.35 1.04 (1.03–1.05) 3.49E-09 6 LOC100507605
rs10751097 11q13.3 69,938,433 A/G 0.4 0.31 1.05 (1.03–1.06) 2.14E-12 0 ANO1
rs497916 11q23.3 118,758,089 T/C 0.28 0.17 1.04 (1.03–1.06) 3.37E-08 0 CXCR5
rs7297628 12q14.2 64,404,555 T/C 0.54 0.75 1.04 (1.03–1.05) 1.39E-08 30 SRGAP1
rs11178634 12q21.1 71,518,329 G/T 0.62 0.7 1.05 (1.03–1.06) 1.36E-11 34 TSPAN8
rs7299936 * 12q24.21 115,934,000 A/G 0.56 0.18 1.04 (1.02–1.05) 3.73E-08 0 MED13L
rs116964464 13q12.13 27,543,193 T/C 0.03 0.04 1.11 (1.07–1.15) 4.83E-09 3 USP12
rs1078563 * 13q34 110,352,851 G/C 0.33 0.28 1.04 (1.03–1.05) 1.53E-08 0 IRS2
rs1497077 14q22.1 52,491,655 C/T 0.66 0.76 1.04 (1.03–1.06) 3.64E-08 0 NID2
rs8031386 15q23 72,508,799 A/C 0.26 0.54 1.04 (1.03–1.06) 4.50E-09 12 PKM2
rs11247566 * 17p13.3 835,371 G/A 0.55 0.52 1.04 (1.02–1.05) 2.92E-08 35 NXN
rs1791373 18p11.31 3,616,779 T/A 0.43 0.14 1.04 (1.03–1.06) 1.13E-08 0 DLGAP1
rs10409772 19p13.3 5,840,926 A/C 0.09 0.29 1.07 (1.05–1.09) 1.33E-10 6 FUT6
rs9983528 21q22.3 47,772,439 A/G 0.13 0.24 1.07 (1.05–1.09) 5.10E-13 0 PCNT
rs4616575 22q12.1 29,406,076 T/G 0.52 0.56 1.04 (1.03–1.05) 1.49E-10 0 ZNRF3
rs130651 22q13.1 39,644,273 G/A 0.33 0.08 1.05 (1.03–1.07) 2.92E-10 46 PDGFB
rs5751474 22q13.2 43,689,542 A/G 0.79 0 1.05 (1.03–1.07) 1.80E-08 52 SCUBE1
rs34256596 * 22q13.2 43,778,431 A/G 0.26 0.4 1.05 (1.03–1.06) 5.86E-09 0 MPPED1
rs9330814 * 22q13.31 46,364,191 T/C 0.33 0.68 1.05 (1.03–1.07) 1.28E-09 33 WNT7B

P-values calculated from a fixed-effects meta-analysis

*

conditional SNP association, with P-values and ORs derived from analysis conditional on known risk loci within 1Mb; RAF, risk allele frequency; EUR, European ancestry population; EAS, East Asian ancestry population; OR, odds ratio; I2, fraction of variance attributable to between study heterogeneity; bp, base pairs. Association statistics for European and East Asian populations are detailed in Supplementary Table 3.